A detailed history of Red Wave Investments LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Red Wave Investments LLC holds 5,996 shares of NVO stock, worth $671,432. This represents 0.34% of its overall portfolio holdings.

Number of Shares
5,996
Previous 6,086 1.48%
Holding current value
$671,432
Previous $781,000 9.48%
% of portfolio
0.34%
Previous 0.31%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$122.71 - $146.91 $11,043 - $13,221
-90 Reduced 1.48%
5,996 $855,000
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $1,633 - $2,174
16 Added 0.26%
6,086 $781,000
Q4 2023

Feb 05, 2024

SELL
$87.78 - $105.45 $4,476 - $5,377
-51 Reduced 0.83%
6,070 $627,000
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $277,639 - $609,195
3,053 Added 99.51%
6,121 $556,000
Q2 2023

Aug 07, 2023

BUY
$155.98 - $172.65 $10,762 - $11,912
69 Added 2.3%
3,068 $496,000
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $10,057 - $12,094
76 Added 2.6%
2,999 $477,000
Q4 2022

Feb 03, 2023

SELL
$102.55 - $135.33 $142,031 - $187,432
-1,385 Reduced 32.15%
2,923 $395,000
Q3 2022

Nov 02, 2022

BUY
$95.28 - $116.93 $571 - $701
6 Added 0.14%
4,308 $429,000
Q2 2022

Aug 09, 2022

SELL
$103.24 - $121.81 $29,629 - $34,959
-287 Reduced 6.25%
4,302 $479,000
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $109,671 - $132,572
1,178 Added 34.54%
4,589 $510,000
Q4 2021

Feb 07, 2022

BUY
$95.88 - $117.08 $19,176 - $23,416
200 Added 6.23%
3,411 $382,000
Q3 2021

Oct 21, 2021

BUY
$84.42 - $106.62 $2,954 - $3,731
35 Added 1.1%
3,211 $308,000
Q2 2021

Aug 10, 2021

BUY
$67.66 - $84.76 $3,721 - $4,661
55 Added 1.76%
3,176 $266,000
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $209,294 - $236,634
3,121 New
3,121 $210,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Red Wave Investments LLC Portfolio

Follow Red Wave Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Wave Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Wave Investments LLC with notifications on news.